Additional Analysis 1
Summary of Estimated Patients 1
Additional Analysis 2
Fremanezumab commentary
TAG CER for Fremanezumab
Summary of Estimated Patients 3
FOI number:
1810-2020
FOI release date:
Publication type:
Report
Audience:
General public
Description:
This request summaries and commentary about the pre-PBAC evaluation of AJOVY (fremanezumab)